Sagimet Biosciences Inc Series A Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -13,953 | -10,650 | -12,191 | -12,908 |
Net Income | -13,953 | -10,650 | -9,568 | -12,908 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -10,698 | -8,611 | -11,833 | -10,180 |
Cash | 165,896 | 36,626 | 35,021 | 32,496 |
Basic Shares | 53,114 | 32,559 | 32,521 | 32,464 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $2,000 | $0 |
Gross Profit | 2,000 | -130 | ||
EBITDA | -51,038 | -45,567 | -27,876 | -31,055 |
EBIT | -54,454 | -61,484 | -31,055 | |
Net Income | -51,038 | -45,567 | -27,876 | -30,499 |
Net Change In Cash | 0 | 0 | 2,000 | 0 |
Free Cash Flow | -45,650 | -42,435 | -23,766 | -24,490 |
Cash | 35,021 | 75,840 | 75,139 | 158 |
Basic Shares | 32,345 | 31,350 | 18,194 | 22,174 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.26 |
2026-03-31 | -$0.33 |
2025-12-31 | -$0.29 |
2025-09-30 | -$0.40 |